LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
43 hedge funds and large institutions have $97.7M invested in LogicBio Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 20 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
43
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.69M | |
| 2 | +$970K | |
| 3 | +$337K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$280K |
| 5 |
State Street
Boston,
Massachusetts
|
+$261K |
Top Sellers
| 1 | -$976K | |
| 2 | -$495K | |
| 3 | -$97.7K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$58K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$12.4K |